EndoAid Ltd. announced that it will receive an equity round of funding from returning investor, Aran Research & Development (1982) Ltd. (TASE:ARAN) on March 30, 2017. The company has entered into an agreement with the investor. Upon completion of the transaction, the investor will hold 69.67% stake in the company at a valuation of $17 million.